This notion is supported by our findings: a high plasma YKL-40 in patients with severe and very severe COPD predicted a worse outcome independent of the traditional disease staging levels (Figure 3B-C). The gene discussed is CHI3L1; the disease is chronic obstructive pulmonary disease.